Literature DB >> 1557230

Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.

V Rodrigues Júnior1, J S Da Silva, A Campos-Neto.   

Abstract

Golden hamsters (Mesocricetus auratus) infected with Leishmania donovani develop a disease similar to human kala-azar. There is conspicuous hypergammaglobulinaemia and their T cells do not respond to stimulation by parasite antigens. The impairment of the cellular immune response seems to be restricted to parasite antigens since infected animals are able to develop a T cell response to the mitogen Concanavalin A (Con-A) and, after sensitization, to the antigens keyhole limpet haemocyanin (KLH) and human serum albumin (DNP-HSA). In the present investigations we studied the role played by infected macrophages in the development of the cellular unresponsiveness present in visceral leishmaniasis. Adherent spleen cells from infected hamsters were unable to present L. donovani antigens to antigen specific T cells, however they were able to present KLH. Conversely, T cells from infected animals did not respond to parasite antigens even when these antigens were presented by normal syngeneic macrophages. Interestingly, lymphocytes from inguinal lymph nodes of infected animals sensitized in their foot pad with parasite antigens proliferated well when stimulated in vitro with L. donovani antigens. These results suggest that the defect in the cellular immune response of the L. donovani infected hamsters is a consequence of a selective inability of their antigen presenting cells to process and present parasite antigens to T cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557230     DOI: 10.1111/j.1365-3024.1992.tb00005.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  13 in total

1.  Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis.

Authors:  Shraddha Kumari; Mukesh Samant; Prashant Khare; Pragya Misra; Sujoy Dutta; Bala Krishna Kolli; Sharad Sharma; Kwang Poo Chang; Anuradha Dube
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

2.  Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis.

Authors:  V Rodrigues; J Santana da Silva; A Campos-Neto
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.

Authors:  A Basu; G Chakrabarti; A Saha; S Bandyopadhyay
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

4.  Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters.

Authors:  Shraddha Kumari; Pragya Misra; Rati Tandon; Mukesh Samant; Shyam Sundar; Anuradha Dube
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

5.  Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.

Authors:  Pramod Kumar Kushawaha; Reema Gupta; Chandra Dev Pati Tripathi; Shyam Sundar; Anuradha Dube
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 6.  Animal models for the study of leishmaniasis immunology.

Authors:  Elsy Nalleli Loría-Cervera; Fernando José Andrade-Narváez
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

7.  Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages.

Authors:  A Campos-Neto; L Soong; J L Cordova; D Sant'Angelo; Y A Skeiky; N H Ruddle; S G Reed; C Janeway; D McMahon-Pratt
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

8.  Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.

Authors:  Reema Gupta; Vikash Kumar; Pramod Kumar Kushawaha; Chandradev Pati Tripathi; Sumit Joshi; Amogh Anant Sahasrabuddhe; Kalyan Mitra; Shyam Sundar; Mohammad Imran Siddiqi; Anuradha Dube
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

9.  Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis.

Authors:  Rahul Shivahare; Preeti Vishwakarma; Naveen Parmar; Pawan Kumar Yadav; Wahajul Haq; Mrigank Srivastava; Suman Gupta; Susanta Kar
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

Review 10.  Experimental models in vaccine research: malaria and leishmaniasis.

Authors:  C Teixeira; R Gomes
Journal:  Braz J Med Biol Res       Date:  2013-02-01       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.